IMMU-32. RETARGETING IMMUNOEDITED GLIOMA ESCAPE VARIANTS WITH ADOPTIVE CELLULAR THERAPY
Publication
, Journal Article
Wildes, T; Dyson, K; Grippin, A; DiVita, B; Flores, C; Mitchell, D
Published in: Neuro-Oncology
November 5, 2018
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 5, 2018
Volume
20
Issue
suppl_6
Start / End Page
vi128 / vi128
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wildes, T., Dyson, K., Grippin, A., DiVita, B., Flores, C., & Mitchell, D. (2018). IMMU-32. RETARGETING IMMUNOEDITED GLIOMA ESCAPE VARIANTS WITH ADOPTIVE CELLULAR THERAPY. Neuro-Oncology, 20(suppl_6), vi128–vi128. https://doi.org/10.1093/neuonc/noy148.535
Wildes, Tyler, Kyle Dyson, Adam Grippin, Bayli DiVita, Catherine Flores, and Duane Mitchell. “IMMU-32. RETARGETING IMMUNOEDITED GLIOMA ESCAPE VARIANTS WITH ADOPTIVE CELLULAR THERAPY.” Neuro-Oncology 20, no. suppl_6 (November 5, 2018): vi128–vi128. https://doi.org/10.1093/neuonc/noy148.535.
Wildes T, Dyson K, Grippin A, DiVita B, Flores C, Mitchell D. IMMU-32. RETARGETING IMMUNOEDITED GLIOMA ESCAPE VARIANTS WITH ADOPTIVE CELLULAR THERAPY. Neuro-Oncology. 2018 Nov 5;20(suppl_6):vi128–vi128.
Wildes, Tyler, et al. “IMMU-32. RETARGETING IMMUNOEDITED GLIOMA ESCAPE VARIANTS WITH ADOPTIVE CELLULAR THERAPY.” Neuro-Oncology, vol. 20, no. suppl_6, Oxford University Press (OUP), Nov. 2018, pp. vi128–vi128. Crossref, doi:10.1093/neuonc/noy148.535.
Wildes T, Dyson K, Grippin A, DiVita B, Flores C, Mitchell D. IMMU-32. RETARGETING IMMUNOEDITED GLIOMA ESCAPE VARIANTS WITH ADOPTIVE CELLULAR THERAPY. Neuro-Oncology. Oxford University Press (OUP); 2018 Nov 5;20(suppl_6):vi128–vi128.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 5, 2018
Volume
20
Issue
suppl_6
Start / End Page
vi128 / vi128
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences